Peter D. Siersema mostly deals with Surgery, Internal medicine, Gastroenterology, Stent and Esophageal disease. His research on Surgery often connects related topics like Radiology. In his study, Inflammation is strongly linked to Endocrinology, which falls under the umbrella field of Internal medicine.
Peter D. Siersema combines subjects such as Incidence, Cohort study, Dysplasia, Retrospective cohort study and Adenocarcinoma with his study of Gastroenterology. His work investigates the relationship between Stent and topics such as Clinical trial that intersect with problems in Lumen and Quality of life. The study incorporates disciplines such as Esophageal stenosis, GERD, Lymph node and Confidence interval in addition to Esophageal disease.
His main research concerns Internal medicine, Surgery, Gastroenterology, Radiology and Esophagus. Peter D. Siersema regularly links together related areas like Oncology in his Internal medicine studies. His study in Surgery concentrates on Stent, Dysphagia, Randomized controlled trial, Esophageal disease and Prospective cohort study.
His research in Dysphagia intersects with topics in Brachytherapy and Esophageal cancer. His Gastroenterology study integrates concerns from other disciplines, such as Reflux, Dysplasia, Incidence and Adenocarcinoma. His Esophagus research incorporates themes from Endoscopy and Pathology.
The scientist’s investigation covers issues in Surgery, Internal medicine, Gastroenterology, Radiology and Colorectal cancer. His work in Surgery tackles topics such as General surgery which are related to areas like Endoscopy. Many of his studies on Internal medicine apply to Oncology as well.
His Gastroenterology research includes elements of Cancer, Hepatocellular carcinoma, Nested case-control study, Hazard ratio and Barrett's esophagus. His Radiology study combines topics in areas such as Neoadjuvant therapy and Adenoma. His Colorectal cancer study combines topics from a wide range of disciplines, such as Cancer registry, Endoscopic resection, Left sided and MEDLINE.
Surgery, Internal medicine, Inflammatory bowel disease, Prospective cohort study and Gastroenterology are his primary areas of study. The various areas that he examines in his Surgery study include Esophagectomy and General surgery. His studies deal with areas such as Case-control study, Ulcerative colitis, Colonoscopy, Crohn's disease and Physical therapy as well as Inflammatory bowel disease.
His Prospective cohort study research includes themes of Body mass index, Radiology and Cohort study. His studies in Gastroenterology integrate themes in fields like Incidence, Adverse effect, Hepatocellular carcinoma, Hazard ratio and Risk factor. His study in Stent is interdisciplinary in nature, drawing from both Decompression, Clinical trial and Fistula.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium.
Toshiro Sato;Daniel E. Stange;Marc Ferrante;Marc Ferrante;Robert G.J. Vries.
Staging investigations for oesophageal cancer: a meta-analysis
E P M van Vliet;M H Heijenbrok-Kal;M G M Hunink;E J Kuipers.
British Journal of Cancer (2008)
Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial
Marjolein Y V Homs;Ewout W Steyerberg;Wilhelmina M H Eijkenboom;Hugo W Tilanus.
The Lancet (2004)
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
Raffaella M Gadaleta;Karel J van Erpecum;Bas Oldenburg;Ellen C L Willemsen.
Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study
Mirthe Emilie van der Valk;Marie-Josée J Mangen;Max Leenders;Gerard Dijkstra.
Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction
Marinke Westerterp;Linetta B. Koppert;Christianne J. Buskens;Hugo W. Tilanus.
Virchows Archiv (2005)
High lifetime risk of cancer in primary sclerosing cholangitis
Marian M.H. Claessen;Frank P. Vleggaar;Kristien M.A.J. Tytgat;Peter D. Siersema.
Journal of Hepatology (2009)
Increasing incidence of Barrett’s oesophagus in the general population
E.M. van Soest;Jeanne Dieleman;Peter Siersema;Miriam Sturkenboom.
Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies.
Maurice W M D Lutgens;Martijn G H van Oijen;Geert J M G van der Heijden;Frank P Vleggaar.
Inflammatory Bowel Diseases (2013)
Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial.
Suzanne M. Jeurnink;Ewout W. Steyerberg;Jeanin E. van Hooft;Casper H.J. van Eijck.
Gastrointestinal Endoscopy (2010)
(Impact Factor: 9.776)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: